Home > Quotes > AZN > Company News

Astrazeneca PLC News Headlines

AZN 
$52.35
*  
0.64
  negative  
1.24%
Get AZN Alerts
*Delayed - data as of May 22, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
View:    AZN After Hours
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Dividend Challengers Smackdown XXI
12/6/2011 1:57:00 PM - Seeking Alpha

A Trading Strategy For 7 Biotech/Healthcare Stocks With Upcoming PDUFA Dates
12/6/2011 5:23:00 AM - Seeking Alpha

Micromet Begins New Trial - Analyst Blog
12/5/2011 12:15:01 PM - Zacks.com

AstraZeneca Adds $100 Million To MedImmune Ventures
12/4/2011 4:10:00 AM - Seeking Alpha

20 Healthcare Stocks Undervalued By Levered Free Cash Flow
12/2/2011 1:25:00 PM - Seeking Alpha

Watson Pharma Going Strong - Analyst Blog
12/2/2011 1:15:01 PM - Zacks.com

DENTSPLY Retained at Outperform - Analyst Blog
12/2/2011 12:30:01 PM - Zacks.com

AstraZeneca Drug Cleared in EU - Analyst Blog
12/1/2011 4:00:01 PM - Zacks.com

Pozen Deal Unlocks Value
11/28/2011 4:26:00 PM - Seeking Alpha

Mid-Day Update: Stocks Keep Most Black Friday Gains; New Home Sales Disappoint
11/28/2011 1:14:41 PM - Midnight Trader

Positive Opinion for AstraZeneca Drug - Analyst Blog
11/21/2011 3:30:01 PM - Zacks.com

Bearish diagonal play in AstraZeneca
11/21/2011 3:14:19 AM - optionMONSTER

AstraZeneca Releases Full SATURN Data - Analyst Blog
11/18/2011 4:45:01 PM - Zacks.com

19 Mega-Cap Stocks Undervalued By Levered Free Cash Flow
11/18/2011 3:06:00 PM - Seeking Alpha

Merck's Vorapaxar Disappoints - Analyst Blog
11/18/2011 1:29:01 PM - Zacks.com

Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
11/18/2011 8:01:00 AM - Seeking Alpha

AstraZeneca: Saturn Trial Will Hamper Revenue Growth
11/18/2011 5:15:00 AM - Seeking Alpha

European Meltdown: What's Next?
11/7/2011 9:12:02 PM - Kapitall

Mid-Day Update: Stocks Firm as Greece Referendum Proceeds; Jobs Gain More Than Expected
11/2/2011 12:20:18 PM - Midnight Trader

Bristol-Myers Reports Stronger 3Q, Lifts Guidance
10/27/2011 9:46:00 AM - Fox Business

Agony From Lipitor's Expiration Won't Be Exclusive To Pfizer
10/10/2011 4:18:00 PM - Seeking Alpha

A Look At AstraZeneca's Current Product Mix And Healthy Dividend
10/10/2011 11:04:00 AM - Seeking Alpha

12 High Dividend, Low Debt, Low PE Stocks
10/10/2011 7:23:00 AM - Seeking Alpha

Large-Cap Global Pharma Stocks May Provide Appreciation and Income
10/7/2011 1:23:00 PM - Seeking Alpha

15 High Dividend Stocks With Strong Fundamentals
10/7/2011 3:52:00 AM - Seeking Alpha